Skip to product information
1 of 3

Plasmanex1 125 mg

Shop for Daiwa Health Development

Regular price $59.90 USD
Regular price Sale price $59.90 USD
Sale
Availability : In Stock

SKU: PNX-60-125-01

UPC : 851814001024

By Daiwa Health Development The active ingredient in Plasmanex 1 ® is Bacillopeptidase F Proprietary Blend (BFPB). BFPB is an... Read more Read more
Size
Category : blood circulation support, Daiwa Health Development
View full details
  • Product Overview
  • Product Benefits
  • Ingredients
  • Dosage/Suggested Use
  • Warnings

The active ingredient in Plasmanex 1 ® is Bacillopeptidase F Proprietary Blend (BFPB). BFPB is an innovative blend of natural ingredients. The complex contains Bacillopeptidase F, a natural soy peptide enzyme extracted by using a patented fermentation process, (Patent No JP3532503). The enzyme is isolated from natto to form a unique molecule shown in scientic research to support healthy blood circulation.

Why is Plasmanex 1 superior to Nattokinase?

Nattokinase is a fibrinolytic protease, which by nature is an enzyme whose basic function is to hydrolyze proteins. Proteins can be broken down to either peptides or peptides and amino acids to make them absorbable. They may also facilitate reduction of plaque formation, but there are no credible clinical trials backing that function.

 

Plasmanex 1 is an NKCP compound that has a multitude of functions, formed by a secret formulation using a fermentation process markedly different from Nattokinase predominantly in the type of bacteria used as well as type of solution. Organisms used are “Halotolerant” that is they survive in mild salt solutions, which would normally kill the bacteria used for the production of Nattokinase.

Halotolerant bacterial concept (used in Plasmanex 1) also leads to a markedly more potent enzyme that has a broader functional capability. Thus the change in bacteria as well as the basic solution make them entirely different products. With markedly higher potency for Plasmanex 1, Nattokinase predominantly effects fibrinogen function, while Plasmanex 1 supports normal PAI-1 levels supporting normal coagulation. Plasminogen Activator Inhibitor -1 (PAI-1) is a protein, which when elevated can increase the risk of thrombosis and atherosclerosis.